Search Within

Han Xiao

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (6)
Groups
  1. Biostatistics Service (16)
  2. Department of Medicine (16)
  3. Epidemiology and Biostatistics (16)
  4. Genitourinary Oncology Service (16)
  5. Solid Tumor Oncology Division (16)
  6. Population Sciences Research Program (6)

More Groups

People
  1. Glenn Heller (7)
  2. Michael Morris (7)
  3. Arlyn Apollo (4)
  4. Jun Mao (4)
  5. Katherine Panageas (4)
  6. Kevin Liou (4)

More People

Years
  1. 2024 (3)
  2. 2023 (5)
  3. 2022 (2)
  4. 2020 (2)
  5. 2019 (1)
  6. 2018 (2)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Annals of Oncology (2)
  3. BMJ Open (1)
  4. Cancer (1)
  5. JAMA Network Open (1)
  6. The Oncologist (1)
Publishers
  1. American Society of Clinical Oncology (10)
  2. Oxford University Press (3)
  3. American Medical Association (1)
  4. BMJ Publishing Group Ltd. (1)
  5. Wiley Blackwell (1)

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical outcomes of patients with metastatic urothelial carcinoma (mUC) discontinuing enfortumab vedotin (EV) monotherapy (mono) without disease progression
    Meeting Abstract

    Sternschuss, M.; Whiting, K.; Teo, M. Y.; Bajorin, D.; Kotecha, R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; Keegan, N.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of sacituzumab govitecan (SG) after prior exposure to enfortumab vedotin (EV) in patients with metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Sternschuss, M.; Toumbacaris, N.; Das, J. P.; Powles, T.; Bajorin, D. F.; Kotecha, R. R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • PRESTO: A phase III, open-label study of intensification of androgen blockade in patients with high-risk biochemically relapsed castration-sensitive prostate cancer (AFT-19)
    Journal Article

    Aggarwal, R.; Heller, G.; Hillman, D. W.; Xiao, H.; Picus, J.; Taplin, M. E.; Dorff, T.; Appleman, L.; Weckstein, D.; Patnaik, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Acupuncture vs massage for pain in patients living with advanced cancer: The IMPACT randomized clinical trial
    Journal Article

    Epstein, A. S.; Liou, K. T.; Romero, S. A. D.; Baser, R. E.; Wong, G.; Xiao, H.; Mo, Z. L.; Walker, D.; MacLeod, J.; Li, Q.; more...
    JAMA Network Open (2023)

    Fulltext@MSK | Save
  • Acupuncture versus massage for pain in patients living with advanced cancer: The IMPACT randomized clinical trial
    Meeting Abstract

    Mao, J. J.; Liou, K.; Romero, S. A. D.; Baser, R. E.; Wong, G.; Xiao, H.; Deng, G.; Mo, Z.; Walker, D.; MacLeod, J. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Depth of PSA nadir and subsequent PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19)
    Meeting Abstract

    Aggarwal, R. R.; Dooley, K.; Hillman, D. W.; Xiao, H.; Picus, J.; Taplin, M. E.; Dorff, T. B.; Appleman, L. J.; Weckstein, D. J.; Patnaik, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Randomized phase III study of enzalutamide compared with enzalutamide plus abiraterone for metastatic castration-resistant prostate cancer (Alliance A031201 trial)
    Journal Article

    Morris, M. J.; Heller, G.; Hillman, D. W.; Bobek, O.; Ryan, C.; Antonarakis, E. S.; Bryce, A. H.; Hahn, O.; Beltran, H.; Armstrong, A. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Baseline characteristics associated with PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19)
    Meeting Abstract

    Aggarwal, R. R.; Heller, G.; Hillman, D. W.; Xiao, H.; Picus, J.; Taplin, M. E.; Dorff, T. B.; Appleman, L. J.; Weckstein, D. J.; Patnaik, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • PRESTO: A phase III, open-label study of androgen annihilation in patients (pts) with high-risk biochemically relapsed prostate cancer (AFT-19)
    Meeting Abstract

    Aggarwal, R.; Heller, G.; Hillman, D.; Xiao, H.; Picus, J.; Wang, J.; Taplin, M. E.; Dorff, T.; Appleman, L. J.; Weckstein, D.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Acupuncture versus massage for pain in patients living with advanced cancer: A protocol for the IMPACT randomised clinical trial
    Journal Article

    Romero, S. A. D.; Emard, N.; Baser, R. E.; Panageas, K.; MacLeod, J.; Walker, D.; Barton-Burke, M.; Liou, K.; Deng, G.; Farrar, J.; more...
    BMJ Open (2022)

    Fulltext@MSK | Save